Aim A longstanding disparity exists between the approaches to restorative surgery after colectomy for patients with ulcerative colitis (UC) in England and Sweden. This study aims to compare rates of colectomy and restorative surgery in comparable national cohorts.
Method The English Hospital Episode Statistics (HES) and Swedish National Patient Register (NPR) were interrogated between 2002 and April 2012. Patients with two diagnostic episodes for UC (age ≥ 15 years) were included. Patients were excluded if they had an episode of inflammatory bowel disease or colectomy before 2002. The cumulative incidences of colectomy and restorative surgery were calculated using the Kaplan-Meier method.
Results A total of 98 691 patients were included in the study, 76 129 in England and 22 562 in Sweden. The 5-year cumulative incidence of all restorative surgery after colectomy in England was 33% vs 46% in Sweden (P-value < 0.001). Of the patients undergoing restorative surgery, 92.3% of English patients had a pouch vs 38.8% in Sweden and 7.7% vs 59.1% respectively had an ileorectal anastomosis (IRA). The 5-year cumulative incidence of colectomy in this study cohort was 13% in England and 6% in Sweden (P-value < 0.001).
Conclusion Following colectomy for UC only onethird of English patients and half of Swedish patients underwent restorative surgery. In England nearly all these patients underwent pouches, in Sweden a less significant majority underwent IRAs. It is surprising to demonstrate this discrepancy in a comparable cohort of patients from similar healthcare systems. The causes and consequences of this international variation in management are not fully understood and require further investigation.
Introduction
Ulcerative colitis (UC) is a relapsing-remitting inflammatory bowel disease (IBD) affecting the rectum and colon in a retrograde pattern of inflammation, starting at the rectum. The majority of patients are managed with medical therapy, but a significant minority will eventually require colectomy [1] . The reported 5-and 10-year cumulative risks of colectomy range from 3-13% to 10-25%, respectively, but no nationwide study has been performed [2] .
In order to live without a permanent ileostomy following a colectomy, patients may choose to undergo restorative surgery in the form of an ileal pouch, ileorectal anastomosis (IRA) or continent ileostomy. In the UK the ileal pouch is the most popular restorative option, but in Sweden patients are more likely to receive an IRA after colectomy [3] . In Sweden it has previously been shown that fewer than half of the patients underwent further restorative surgery after a colectomy for IBD [4] . Whether the situation is similar in England is unknown, and whether the cumulative risk of colectomy could explain potential differences needs further exploration.
This study aims to utilize national routinely collected administrative data to investigate the differences in the surgical management of patients with UC in England and Sweden, particularly with regard to the comparative likelihood of patients undergoing restorative surgery after colectomy in the two countries.
Method The English nationwide registers
The English National Health Service (NHS) Hospital Episode Statistics (HES) data have been described previously [5] . They include diagnostic, procedural, demographic and geographical data for all NHS secondary care episodes in England. There is a very small minority of patients receiving private healthcare in NHS hospitals. The HES data are linked to Office of National Statistics (ONS) data to record death outside of hospital. , although this will be higher if only three-digit diagnostic coding is used, as is the case in this study [6] .
The Swedish nationwide registers
The Swedish nationwide population-based registers of patient care, cancer, causes of death and emigration were used [7] [8] [9] . The Swedish healthcare service is available to all residents, to whom unique personal identification numbers are assigned, making it possible to identify all residents and follow them through register linkages [10] . Swedish 
Study population
The nationwide English and Swedish data were used to identify incident cases of UC between April 1997 and April 2012. Patients were included in the study if they had two separate events (inpatient episodes including endoscopy visits and visits for administration of biological drugs in England, and inpatient or nonprimary outpatient episodes in Sweden) with a primary or secondary diagnostic code for UC (ICD-10: K51) between January 2002 and April 2012. Patients were excluded if they were diagnosed with UC before the age of 15 years. Patients were also excluded from the study if they had a diagnostic episode for UC or Crohn's disease (CD; ICD-10: K50), colectomy or restorative surgery before 2002. A 'washout period' of at least 5 years was used to select a population who had neither been diagnosed with IBD nor undergone a colectomy before 2002.
Patients were followed longitudinally from their first episode with a diagnostic code for UC until 30 April 2012, date of death or date of emigration (in Sweden only), whichever came first.
UC surgery
The OPCS and NOMESCO procedural codes are included in Appendix S1 for England and Sweden, respectively, and were used to identify patients in whom colectomy and restorative procedures (IRA, pouch or continent ileostomy) were performed. Primary IRA and pouch surgery were defined as procedures performed in conjunction with the colectomy, whereas secondary IRA and pouch surgery were restorative surgeries performed at a later stage. Only the first restorative surgery was accounted for. On preliminary analysis of the English data it was clear that the code for continent ileostomy (G74.1) was used inaccurately as a code for ileostomy, with over 400 recorded procedures. This code was excluded from the English analysis.
Covariates
Patients were classified into five categories according to age at diagnosis of UC (15- K83.00 were extracted from the registers at the time of UC diagnosis as well as at the time of colectomy. The Cancer Register was used in Sweden to identify diagnosis of colorectal cancer (ICD-7: 153 and 1540) before UC diagnosis and at the time of colectomy. In England ICD-10 codes for colorectal cancer were used, namely C18-C20.
Analysis
Descriptive statistics were performed on demographic and diagnostic variables shared between both national registries as described above. The cumulative incidence of colectomy and restorative surgery was estimated using the Kaplan-Meier method, and the log-rank test was used to calculate P-values. English HES data were analysed in SPSS (IBM SPSS Statistics for Windows, version 20.0, IBM Corp., Armonk, New York, USA) and Swedish data with STATA 14 (StataCorp, College Station, Texas, USA). Statistical tests were two-sided and statistical significance was set at P ≤ 0.05. The researchers only had access to de-identified data. The study had been approved by the ethical vetting board in London (HRA NRES 2013: REC Reference 13/LO/1235) and in Stockholm, Sweden (DNR of ethical approvals including amendments: 2007/785-31/5; 2015/1030-32). The study is reported as per the STROBE guidelines [11] .
Sensitivity analysis
The total national populations were also used as denominators, using the 2007 population for each country as this was the mid-point of follow-up [12, 13] .
Results
In total 98 691 patients were included in the study, 76 129 in England and 22 562 in Sweden (Fig. 1) . Table 1 shows the demographic data for patients included in the study. The gender distribution was similar in the two cohorts while the median age at the first UC episode was younger in the Swedish cohort (42 vs 52 years). The maximum length of follow-up was 10.25 years. The mean average length of follow-up was 5.15 years in the English cohort and 5.27 years in the Swedish cohort.
Colectomies
During follow-up 10 557 colectomies were performed. Colectomy was performed in 12% (n = 9118) of the English patients and 6% (n = 1439) of the Swedish patients (Fig. 1, Table 2 ). There was no difference in age at colectomy, or presence of colorectal cancer prior to colectomy, but more Swedish patients had diagnostic codes for primary sclerosing cholangitis listed in admissions up to the time of colectomy (3% vs 1%). The cumulative incidence of colectomy at 5 years was 13% in England and 6% in Sweden (Table 3 , Fig. 2 ) (P-value < 0.001).
Sensitivity analysis
A sensitivity analysis was performed using the total population as the denominator (Table 4 in Sweden (1439/ 9 182 927) (P-value < 0.001).
Restorative surgery
The crude rate of restorative surgery after colectomy in England was 29.6% vs 41.4% in Sweden. Table 5 and Fig. 3 show that the cumulative incidence in England and Sweden at 1 year was 0.24 and 0.29, at 3 years 0.32 and 0.43, and at 5 years 0.33 and 0.46, respectively (P-value < 0.001).
After colectomy in England and Sweden, 27.6% vs 16.1% of patients underwent pouch operations and 2.3% vs 24.5% underwent IRA, respectively. As a proportion of restorative procedures, pouches accounted for 92.3% in England and 38.8% in Sweden, and IRAs 7.7% and 59.1%, respectively.
Discussion
The main finding from this study is that the rate of restorative surgery for UC patients undergoing colectomy is lower in England than in Sweden. Only onethird of patients in England underwent a restorative procedure within 5 years of undergoing a colectomy compared with nearly half in Sweden. The data have also confirmed that the choice of restorative procedure differs in the two countries. During the study period 92% of the English patients undergoing restorative surgery had an ileal pouch whereas in Sweden 59% of restorative procedures were an IRA and only 39% a pouch. This study suggests that the colectomy rate is higher in England than in Sweden, but this finding should be treated with caution and is discussed later in this section. This paper reports the first international comparison of two nationwide cohorts of patients with UC undergoing surgery. As global benchmarking and shared international experience in healthcare are becoming more commonplace, this study contributes to the literature by highlighting discrepancy in the management of the same condition in two developed healthcare systems.
Surprisingly only one-third of the UC patients in England underwent restorative surgery following a colectomy. The corresponding number was higher in Sweden, but still under 50%. The reasons for this comparatively low proportion of young patients undergoing restorative surgery are uncertain. The reasons for the surprisingly low rate of restorative surgery are unknown and probably multifactorial. For a patient to undergo restorative surgery for UC factors related to the patient and surgeon/hospital have to be considered. The patient must be a suitable candidate with regard to their sphincter function and disease-related factors and they must be aware of the option for restorative surgery and have a preference for avoiding a permanent ileostomy. The surgical team must ensure that the patient is well informed and given a balanced view regarding a permanent ileostomy vs restorative surgery. Previous research in Sweden and New York has suggested that patients undergoing their colectomy in low-volume restorative surgery centres have a lower risk of subsequent restorative surgery [4, 14] . In New York, patient-related factors influenced subsequent pouch surgery more than surgeon-related factors. It is not known if the same volume outcome relationship is true in England, and this should be the subject of future research.
One difference between the two countries is the surgical procedure employed. In England almost all patients received a pouch while in Sweden IRA was the most commonly used technique. The long-term implications for quality of life when comparing reconstruction with a pouch with IRA are yet to be established. One perceived advantage with pouch surgery is the lower failure rate compared with that following an IRA [15] [16] [17] . It should, however, be noted that failure of an ileal pouch necessitates permanent ileostomy (although conversion to continent ileostomy is technically possible but rarely performed [18] ), whereas failure of an IRA leaves the option of conversion to a pouch. In a previous Swedish NPR study including 265 patients in whom IRA failed, 76 (28.7%) were converted to a pouch. The function following conversion of an IRA to a pouch seems reasonable in patients with familial adenomatous polyposis, and probably in patients with UC [19, 20] . Another disadvantage with IRA is the potential risk of cancer, and yearly surveillance of the rectal remnant is needed [21, 22] . IRAs have the perceived advantage of being less technically demanding and, in combination with careful patient selection and medical management of the rectal remnant, may represent an interim measure for some patients requiring colectomy. An algorithm for the management of the rectum after colectomy has been published previously, and includes topical 5-aminosalicylic acid enemas to reduce inflammation and increase rectal compliance [23] .
Beyond the advantages and disadvantages described above, it is not known why the discrepancy in the choice of restorative options exists between England and Sweden. The pouch was developed and popularized in the UK, but this does not explain the preference in North America and many other European countries. It is possible that ulcerative colitis is phenotypically different in Sweden, with relative rectal sparing, and so IRAs are better tolerated by patients. It may be explained by the greater geographical distances to specialist colorectal hospitals in Sweden, making access to surgeons performing pouch surgery more difficult than in the UK. These points are speculative, and should be answered in further research studies. There has been a reappraisal of IRA in Sweden prompted by the desire to avoid the impact on female fecundity associated with pelvic surgery. There are now more effective medical treatment options and more sensitive endoscopic surveillance than when the pouch was developed, and in very select patients an IRA is an appropriate first restorative procedure [23] .
This is the first nationwide study comparing the cumulative risk of colectomy in UC patients in two countries. The 5-year cumulative risk of colectomy was lower in Sweden than in England. When interpreting the English data it should be noted that it is difficult to define the true size of the UC population due to a lack of reliable outpatient diagnostic coding (therefore outpatient HES data were not used for this study). The HES data for care of admitted patients used for this study do include endoscopy visits and administration of high-cost medications by infusion. Because of the likelihood of a patient with UC requiring at least one endoscopy over a 10-year period (and most patients undergo an endoscopy at the time of UC diagnosis), we believed that most UC patients would be captured. Given, however, that the 5-year cumulative risk of colectomy in England was twice as high as in Sweden but the number of UC colectomies per 100 000 total population was similar in the two countries it is likely that not all English UC patients were identified. The NPR has more reliable outpatient data and has been validated for capturing IBD patients with a positive predictive value for true IBD of 93% with two diagnoses of IBD and 79% for two diagnoses of UC [24] . The validity of HES for identifying patients with IBD has not been confirmed in a similar fashion. This study is a unique comparison of the surgical management of comparable nationwide cohorts of UC patients from two healthcare systems in which universal patient identification allows longitudinal tracking. Nationwide, population-based data collected in routine medical care reflect real-world practice as opposed to the strict conditions of controlled trials, and the very large sample size results in excellent precision. The 10-year follow-up period is adequate, as over 90% of patients undergoing restorative surgery have done so by 3 years after colectomy. A washout period of at least 5 years was used to ensure that we captured only incident cases. The Swedish cohort is based on the NPR with a complete registration of in-hospital as well as outpatient visits and a validated method of capturing IBD cases. The English cohort is based on HES data with validated accuracy regarding diagnostic and procedural coding [25] . However, it is possible that not all English UC patients were identified in the HES data, and that the true cumulative risk of colectomy is indeed lower than reported in this study. It should be noted that this weakness is unlikely to affect the capture of true UC colectomies as HES covers all of the inpatient population. Therefore, the gross number of colectomies and the rate of restorative surgery can be considered reliable.
With regard to other weaknesses of the methodology, some are inherent to all international comparison studies of administrative healthcare data; namely procedural coding discrepancies, clinician vs professional coder input of data and limited comparable clinical outcome measures [26] . As in most registry studies there was no detailed clinical information available. It is possible that the differences in colectomy and restorative rates between England and Sweden could be explained by differences in disease phenotype and administered drugs -information that could not be attained reliably in both data sets.
This study raises questions about how gastroenterology and colorectal management practices differ in the two countries with regard to counselling and preparing patients for permanent stoma, pouch or IRA. Also it questions what the long-term implications are for quality of life in patients reconstructed with a pouch vs an IRA.
Conclusion
Following a UC colectomy, only one-third of English patients and nearly half of Swedish patients undergo restorative surgery. In England nearly all these patients underwent pouches and a less significant majority in Sweden underwent IRAs. It is surprising to demonstrate such a discrepancy in a comparable cohort of patients from two similar healthcare systems. The reasons for and consequences of this international variation in management are not fully understood and require further investigation to establish the best possible care for patients requiring surgery for UC.
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